Keitaro Hayashi

Years Active: 2019-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Keitaro Hayashi, Mayumi Saeki, Kento Miura, Norimasa Yamasaki, Masaya Matsuda, Hayato Shimora, Takeshi Nabe, Yasuo Shimizu, Tomoe Fujita, Hitoshi Endou, Osamu Kaminuma
JPH203, a LAT1 inhibitor, alleviates steroid-resistant murine airway inflammation mediated by Th17 cells. Allergy (2023)
Keitaro Hayashi, Osamu Kaminuma
Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1. Biomolecules 12 (4) (2022)
Daiki Ito, Kento Miura, Mayumi Saeki, Norimasa Yamasaki, Sawako Ogata, Teidai Koyama, Takachika Hiroi, Akio Mori, Hitoshi Endou, Keitaro Hayashi, Osamu Kaminuma
L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation. Asia Pacific allergy 11 (3) (2021)
Keitaro Hayashi, Osamu Kaminuma, Tomoe Nishimura, Mayumi Saeki, Kunie Matsuoka, Takachika Hiroi, Promsuk Jutabha, Yohei Iwata, Kazumitsu Sugiura, Takayoshi Owada, Kazuhiro Kurasawa, Isao Okayasu, Motoshi Ouchi, Tomoe Fujita, Yoshikatsu Kanai, Hitoshi Endou, Naohiko Anzai
LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation. Allergy 75 (2) (2019)

Keitaro Hayashi.css-eqlu8i{font-size:small;padding-left:4px;}